Abstract Details
|
Deepak Kalra, MD, PhD, MPH
PRESENTER |
Dr. Kalra has nothing to disclose. |
| Srivadee Oravivattanakul, MD (Austin Diagnostic Clinic) | Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. |
| Douglas K. Sato, MD | Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck. |